Position in AMGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,476,363
-$23,573 QoQ
Shares Held
4,077
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,443
of 3,149 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. AMGN ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
This page
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,476,363 | 4,077 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,499,936 | 4,263 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,413,324 | 4,318 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,767,983 | 6,265 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,773,821 | 6,353 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,345,659 | 7,529 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,778,161 | 10,659 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,595,863 | 11,160 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,470,382 | 11,107 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $3,043,076 | 10,703 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,024,498 | 10,501 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,849,393 | 10,602 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,271,264 | 10,230 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,493,893 | 10,316 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,715,172 | 10,338 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,323,423 | 10,308 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,530,563 | 10,401 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,634,628 | 10,895 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,290,644 | 10,182 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,954,040 | 9,189 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $2,296,125 | 9,420 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,270,888 | 9,127 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,112,734 | 9,189 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,634,248 | 6,430 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $1,461,683 | 7,210 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||